These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 1685407)

  • 1. Effect of some arsenic antagonists on the toxicity, distribution and excretion of arsenite and arsenate in rats.
    Hilmy AM; el-Domiaty NA; Kamal MA; Mohamed MA; Abou Samra WE
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1991; 99(3):357-62. PubMed ID: 1685407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DMSA, DMPS, and DMPA--as arsenic antidotes.
    Aposhian HV; Carter DE; Hoover TD; Hsu CA; Maiorino RM; Stine E
    Fundam Appl Toxicol; 1984 Apr; 4(2 Pt 2):S58-70. PubMed ID: 6327446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of selenite on the disposition of arsenate and arsenite in rats.
    Csanaky I; Gregus Z
    Toxicology; 2003 Apr; 186(1-2):33-50. PubMed ID: 12604169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutathione-dependent biliary excretion of arsenic.
    Gyurasics A; Varga F; Gregus Z
    Biochem Pharmacol; 1991 Jul; 42(3):465-8. PubMed ID: 1859460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of three antidotes on arsenic toxicity in the common earthworm (Lumbricus terrestris).
    Li W; Chien PK; Furst A
    J Appl Toxicol; 1994; 14(3):181-3. PubMed ID: 7521893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The metabolism of arsenite and arsenate by the rat.
    Lerman S; Clarkson TW
    Fundam Appl Toxicol; 1983; 3(4):309-14. PubMed ID: 6628893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue distribution and urinary excretion of dimethylated arsenic and its metabolites in dimethylarsinic acid- or arsenate-treated rats.
    Adair BM; Moore T; Conklin SD; Creed JT; Wolf DC; Thomas DJ
    Toxicol Appl Pharmacol; 2007 Jul; 222(2):235-42. PubMed ID: 17559899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amelioration by BAL (2,3-dimercapto-1-propanol) and DMPS (sodium 2,3-dimercapto-1-propanesulfonic acid) of arsenite developmental toxicity in mice.
    Domingo JL; Bosque MA; Llobet JM; Corbella J
    Ecotoxicol Environ Saf; 1992 Jun; 23(3):274-81. PubMed ID: 1376232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of glutathione in reduction of arsenate and of gamma-glutamyltranspeptidase in disposition of arsenite in rats.
    Csanaky I; Gregus Z
    Toxicology; 2005 Feb; 207(1):91-104. PubMed ID: 15590125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracellular interaction and metabolic fate of arsenite and arsenate in mice and rabbits.
    Vahter M; Marafante E
    Chem Biol Interact; 1983 Oct; 47(1):29-44. PubMed ID: 6640784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arsenic-induced dyslipidemia in male albino rats: comparison between trivalent and pentavalent inorganic arsenic in drinking water.
    Afolabi OK; Wusu AD; Ogunrinola OO; Abam EO; Babayemi DO; Dosumu OA; Onunkwor OB; Balogun EA; Odukoya OO; Ademuyiwa O
    BMC Pharmacol Toxicol; 2015 Jun; 16():15. PubMed ID: 26044777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strain-dependent disposition of inorganic arsenic in the mouse.
    Hughes MF; Kenyon EM; Edwards BC; Mitchell CT; Thomas DJ
    Toxicology; 1999 Sep; 137(2):95-108. PubMed ID: 10521146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism and excretion of gallium arsenide and arsenic oxides by hamsters following intratracheal instillation.
    Rosner MH; Carter DE
    Fundam Appl Toxicol; 1987 Nov; 9(4):730-7. PubMed ID: 3692028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolated rat kidney tubules as a screening system for arsenic antidotes.
    Mückter H; Islambouli S; Doklea E; Hopfer C; Szinicz L; Fichtl B; Forth W
    Toxicol Appl Pharmacol; 1993 Jul; 121(1):118-28. PubMed ID: 8393218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accumulation and metabolism of arsenic in mice after repeated oral administration of arsenate.
    Hughes MF; Kenyon EM; Edwards BC; Mitchell CT; Razo LM; Thomas DJ
    Toxicol Appl Pharmacol; 2003 Sep; 191(3):202-10. PubMed ID: 13678653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Embryotoxicity of arsenite and arsenate: distribution in pregnant mice and monkeys and effects on embryonic cells in vitro.
    Lindgren A; Danielsson BR; Dencker L; Vahter M
    Acta Pharmacol Toxicol (Copenh); 1984 Apr; 54(4):311-20. PubMed ID: 6730986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the effect of BAL (2,3-dimercaptopropanol) on arsenite-induced teratogenesis in mice.
    Hood RD; Vedel-Macrander GC
    Toxicol Appl Pharmacol; 1984 Mar; 73(1):1-7. PubMed ID: 6710506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological chelation: 2,3-dimercapto-propanesulfonic acid and meso-dimercaptosuccinic acid.
    Aposhian HV
    Adv Enzyme Regul; 1982; 20():301-19. PubMed ID: 6287818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Species variations in the biliary and urinary excretion of arsenate, arsenite and their metabolites.
    Csanaky I; Gregus Z
    Comp Biochem Physiol C Toxicol Pharmacol; 2002 Mar; 131(3):355-65. PubMed ID: 11912060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of trimethylselenonium versus selenite in cancer chemoprevention and its modulation by arsenite.
    Ip C; Ganther H
    Carcinogenesis; 1988 Aug; 9(8):1481-4. PubMed ID: 3402045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.